Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
15 hedge funds and large institutions have $204K invested in Peak Bio, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
12% less funds holding
Funds holding: 17 → 15 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
67% less capital invested
Capital invested by funds: $613K → $204K (-$409K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$46.9K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$19K |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$3.48K |
| 4 |
HF
HRT Financial
New York
|
+$3.44K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
+$1.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$499K |
| 2 |
CCFM
Cohen & Co Financial Management
New York
|
-$35K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$6K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2K |
PKBOW Hedge Fund Activity: Q4 2022 in Review
15 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q4 2022, worth a combined $204K — down 67% from $613K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of PKBOW and 5 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was EHP Funds Inc, opening a new position worth an estimated $46.9K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $499K sold.
- 15 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q4 2022, down from 17 in Q3 2022.
- Funds reported $204K of Peak Bio, Inc. Warrant stock for Q4 2022, down 67% quarter-over-quarter.
- 5 funds opened new Peak Bio, Inc. Warrant positions in Q4 2022 and 7 closed out, a net change of -2 holders.
- The largest Peak Bio, Inc. Warrant buyer in Q4 2022 was EHP Funds Inc, an estimated $46.9K added.
- The largest Peak Bio, Inc. Warrant seller in Q4 2022 was Radcliffe Capital Management, an estimated $499K sold.
Based on aggregated 13F filings for Q4 2022.